explore -WSS

explore

author：hotspot 2025-10-03 00:38:08 - browse：535

Two boxes of Ozempic stack on each other, while one lean on the stack tilted — health coverage from STAT — SEBASTIEN BOZON/AFP via Getty Images

Novo Nordisk’s Ozempic cut the risk of death in a trial of patients with type 2 diabetes and chronic kidney disease, suggesting it may offer some added benefits over other classes of drugs approved to treat this population.

Specifically, the diabetes drug cut the risk of cardiovascular-related deaths by 29% and all-cause deaths by 20%. Given the study parameters, this implies that over three years, 39 people would need to be treated to prevent one death from any cause, according to new results presented Friday at a meeting of the European Renal Association and published in the New England Journal of Medicine.

Ozempic also lowered the risk of major heart complications — including cardiovascular-related death, heart attack, or stroke — by 18%, driven primarily by the reduced rate of heart-linked death.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Anesthesiologist group: stop taking Ozempic before surgery

hotspot

WSS

At least 13 dead in Texas as scorching temps continue

DeSantis and Newsom agree to Sean Hannity debate, then disagree on the rules

Apple is now the first public company to be valued at $3 trillion

Illinois to ban advertising for guns allegedly marketed to kids and militants

Biden will tout long

Guidelines to prevent youth baseball injuries need more muscle

leisure time

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

At least 13 dead in Texas as scorching temps continue

George Santos makes 1st court appearance after pleading not guilty to 13 counts

BioMarin wins approval for gene therapy to treat hemophilia A

Medicare details structure of new drug price negotiation program

What does generative AI mean for health care? We asked experts

Bursting ice dam in Alaska highlights risks of glacial flooding around the globe

George Santos makes 1st court appearance after pleading not guilty to 13 counts

At least 13 dead in Texas as scorching temps continue

As demand for Covid shots wanes, Moderna seeks its next success

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

entertainment

Trump Jan. 6 attorney John Lauro is ex

Democratic lawmaker calls for 'well

Boeing's 1st astronaut flight bumped into next year, more repairs needed

Hollywood unions extend contract negotiations for actors

Walensky prepares to leave CDC — and Congress — behind

Trump demands the U.S. pay no more for drugs than other countries … again

Wikipedia

hotspot

hotspot

entertainment